mifepristone

You have access
Palliative Benefits of Oral Mifepristone for the Treatment of Metastatic Fibroblastic Osteosarcoma
JEROME H. CHECK, DIANE CHECK, TRINA PORETTA and CARRIE WILSON

Anticancer Research April 2021, 41 (4) 2111-2115; DOI: https://doi.org/10.21873/anticanres.14982
You have access
Mifepristone Extends Both Length and Quality of Life in a Patient With Advanced Non-small Cell Lung Cancer that Has Progressed Despite Chemotherapy and a Check-point Inhibitor
JEROME H. CHECK, DIANE CHECK and TRINA PORETTA

Anticancer Research April 2019, 39 (4) 1923-1926; DOI: https://doi.org/10.21873/anticanres.13301
You have access
Mifepristone Has Limited Activity to Enhance the In Vivo Efficacy of Docetaxel and Enzalutamide Against Bone Metastatic and Castration-Resistant Prostate Cancer
YANG YANG, XIN LI, KENZA MAMOUNI, OMER KUCUK and DAQING WU

Anticancer Research November 2017, 37 (11) 6235-6243;
You have access
Long-term High-quality Survival with Single-agent Mifepristone Treatment Despite Advanced Cancer
JEROME H. CHECK, DIANE CHECK, CARRIE WILSON and PATRICE LOFBERG

Anticancer Research December 2016, 36 (12) 6511-6513;
You have access
Mifepristone Causing Complete Remission of Rapidly Advancing Leukemia with Measurement of Progesterone-induced Blocking Factor
JEROME H. CHECK, DIANE CHECK, RACHAEL COHEN and MOJIRAYO SARUMI

Anticancer Research May 2014, 34 (5) 2413-2416;

Main menu